Similar articles

• Immunomodulatory properties of recombinant murine and human tumor necrosis factor.

  Talmadge JE, Phillips H, Schneider M, Rowe T, Pennington R, Bowersox O, Lenz B. Talmadge JE, et al. Cancer Res. 1988 Feb 1;48(3):544-50. Cancer Res. 1988. PMID: 3257167
• Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.

  Browning JL, Sizing ID, Lawton P, Bourdon PR, Rennert PD, Majeau GR, Ambrose CM, Hession C, Miatkowski K, Griffiths DA, Ngam-ek A, Meier W, Benjamin CD, Hochman PS. Browning JL, et al. J Immunol. 1997 Oct 1;159(7):3288-98. J Immunol. 1997. PMID: 9317127
• Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.

  Bialas T, Kolitz J, Levi E, Polivka A, Oez S, Miller G, Welte K. Bialas T, et al. Cancer Res. 1988 Feb 15;48(4):891-8. Cancer Res. 1988. PMID: 3257413
• [Cellular immunity mediators in viral diseases (a review of the foreign literature)].

  Shepel' NG. Shepel' NG. Veterinariia. 1978 Mar;(3):109-13. Veterinariia. 1978. PMID: 347691 Review. Russian. No abstract available.
• [Mediators in cellular immunity (author's transl)].

  Sawada J, Osawa T. Sawada J, et al. Tanpakushitsu Kakusan Koso. 1974 Sep 17;19(10):860-75. Tanpakushitsu Kakusan Koso. 1974. PMID: 4612616 Review. Japanese. No abstract available.